Many by researchers supported by the PCF.

Even more dramatically, 90 new treatments are in Phase II clinical trials currently, compared with only 31 in 1997. Information concerning prostate tumor therapies in clinical advancement is now available at the PCF’s Prostate Tumor Therapeutics Resource Center ( section of the Prostate Cancer Foundation’s newly redesigned Web site, accessible at Related StoriesSausages With Antioxidants From Berries TO AVOID CancerMD Anderson research reveals why chemotherapy drugs not effective for most pancreatic tumor patientsNew RNA check of blood platelets may be used to identify area of cancerProstate Cancer Basis CEO Leslie D.Atrial fibrillation can be a problem seen in older individuals predominantly, who develop it at very high rates, despite the fact that they possess a shorter remaining lifespan where to get it. The high life time dangers reported in this study underscore the major public wellness burden posed by atrial fibrillation and the need for additional investigation into predisposing circumstances, preventive strategies and far better therapies, he stated.9-million testing facility. Testing for stimulants, masking agents, insulin and glucocorticosteroids will be run on a mass spectrometry solution provided by AB SCIEX, a global leader in life research analytical technologies.